Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. BiondVax Pharmaceuticals Ltd. (BVXV) Message Board

Shining the Spotlight on Asthma During Pregnancy

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 122
(Total Views: 171)
Posted On: 07/18/2023 4:56:14 PM
Avatar
Posted By: NetworkNewsWire
Shining the Spotlight on Asthma During Pregnancy

Asthma is a respiratory condition that affects around 9.7% of adult women and 6.2% of adult males. Researchers believe the condition is more prevalent in girls and women as fluctuating levels of hormones, including progesterone and estrogen, can affect a woman’s airways.

For women with asthma, pregnancy comes with additional risks. Pregnancy by itself is a risky endeavor that often puts incredible mental and physical strain on expectant mothers. With the presence of asthma, pregnant asthmatic women can find it extra hard to breathe during asthma attacks; such attacks can reduce the amount of oxygen going to the fetus and result in issues such as developmental delays and growth abnormalities.

Compared to healthy women, women with asthma are slightly more likely to develop high blood pressure during pregnancy. They also have a higher risk of preeclampsia, a high blood pressure disorder in pregnant women that is characterized by disruptions in the function of blood vessels in the placenta. Preeclampsia can lead to the development of general high blood pressure and cause damage to the brain, kidneys, liver and other organs in pregnant mothers.

Uncontrolled asthma in asthmatic pregnant women can result in abnormally slow fetus growth by limiting the oxygen supply to the baby as well as preterm births, lower-than-usual birth weights, and even death while still in-utero or after birth. Consequently, it is crucial that asthmatic women engage with their healthcare providers to develop asthma action plans before or when they get pregnant to help protect both the mother’s and baby’s health.

Such a plan would limit inflammation in the airways and reduce the number of asthma attacks the mother suffers while pregnant. The first move would be to connect an asthma doctor with an obstetrician and make sure they discuss how to handle treatment for the duration of pregnancy.

Pregnant women should also contact their doctor or seek emergency aid right away if they notice that the baby is moving less than usual during or after an asthma attack as even a few minutes of oxygen deprivation can cause fetal death. Regular ultrasounds will allow an obstetrician to monitor the fetus’ growth and will be especially helpful in checking a baby’s condition after a women experiences an asthma attack. Pregnant women will also want to avoid asthma triggers such as dust mites and tobacco to avoid triggering a new asthma attack.

If asthma attacks are caused by allergies, a physician may recommend treating the allergies to keep the asthma at bay during pregnancy.

Companies such as BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) are seeking to develop better therapeutics against autoimmune conditions, including allergies, so that different groups of patients, such as pregnant women, can effectively manage those illnesses while enjoying a better quality of life.

NOTE TO INVESTORS: The latest news and updates relating to BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) are available in the company’s newsroom at https://ibn.fm/BVXV

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer




(0)
(0)




BiondVax Pharmaceuticals Ltd. (BVXV) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us